ACT

TEAMSTERS CALL ON LAWMAKERS TO PASS TEMP BILL

Retrieved on: 
Wednesday, February 7, 2024

ALBANY, N.Y., Feb. 7, 2024 /PRNewswire/ -- Yesterday, the Teamsters were joined by their allies at the New York Committee for Occupational Safety and Health, La Colmena, the National Employment Law Project, the Retail Wholesale Department Store Union (RWDSU), and WE ACT for Environmental Justice in calling on the New York Senate and General Assembly to pass the Temperature Extreme Mitigation (TEMP) Act (S1604/A8935).

Key Points: 
  • "By enacting the TEMP Act, we ensure that protections are consistently put into effect, safeguarding the well-being of our workforce both in the present and for generations to come."
  • "Our workers and communities face dire consequences without immediate action," said Jeffrey Brylski, President of Teamsters Joint Council 46.
  • Founded in 1903, the International Brotherhood of Teamsters represents 1.3 million hardworking people in the U.S., Canada, and Puerto Rico.
  • Follow us on Twitter @Teamsters and "like" us on Facebook at Facebook.com/teamsters .

Shaping the Future of Sustainable Freight: ACT Shipper-Carrier Connect Debuts in Las Vegas Alongside ACT Expo 2024

Retrieved on: 
Wednesday, February 7, 2024

Santa Monica, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Today, organizers of the Advanced Clean Transportation (ACT) Expo , recognized as the largest event in advanced commercial vehicle technology, announced the inaugural ACT Shipper-Carrier Connect – scheduled for May 22-23, 2024, at the Las Vegas Convention Center, co-located with ACT Expo.

Key Points: 
  • Santa Monica, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Today, organizers of the Advanced Clean Transportation (ACT) Expo , recognized as the largest event in advanced commercial vehicle technology, announced the inaugural ACT Shipper-Carrier Connect – scheduled for May 22-23, 2024, at the Las Vegas Convention Center, co-located with ACT Expo.
  • ACT Shipper-Carrier Connect will serve as a collaborative forum, bringing together shippers, carriers, and logistics providers to collectively shape the future of sustainable freight, identifying practical opportunities to achieve shared economic and environmental sustainability goals.
  • ACT Shipper-Carrier Connect will convene the key stakeholders from the North American road freight value chain.
  • This discussion is set against the backdrop of ACT Expo, where improved clean vehicle availability and improved total cost of ownership for some advanced technology vehicles will be on display.

January StandOut® Challenge Interview Levels College Admissions by Probing Directly for the Independent Variables of Academic and Career Success

Retrieved on: 
Wednesday, February 7, 2024

Peer review and evaluation requires each candidate to listen to, learn from and make judgments about what others are saying.

Key Points: 
  • Peer review and evaluation requires each candidate to listen to, learn from and make judgments about what others are saying.
  • These three top-scorers in January’s StandOut® Challenge Interview competition won the following scholarships:
    The February 2024 StandOut Challenge Interview competition is now underway.
  • CollegeNET is awarding a total of $200,000 in scholarships to students who plan to attend schools participating in the StandOut Admissions Network.
  • Schools wishing to join other institutions in the StandOut Admissions Network are welcome to contact CollegeNET .

The New York Academy of Medicine Launches Initiative to Build Health Systems Resilience

Retrieved on: 
Wednesday, February 7, 2024

New York, NY, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM), an innovator in public health for more than 176 years, launches its first initiative in a multiyear plan to help build more resilient health systems in the era of climate change.

Key Points: 
  • New York, NY, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM), an innovator in public health for more than 176 years, launches its first initiative in a multiyear plan to help build more resilient health systems in the era of climate change.
  • NYAM’s Designing Health Systems Resilience program will begin to establish a community of practice among health executives, public health officials, payers, and policy-makers as a first step toward building a “Roadmap to Resilience,” providing recommendations for programming and partnerships to support healthcare and public health system resilience across New York.
  • Designing Health Systems Resilience is made possible by the generosity of our sponsors, including the Commonwealth Fund, Mount Sinai Health System, Netflix, and Northwell Health, and our media partner City & State New York.
  • Future phases of NYAM’s work with public health and health systems will explore support of resilience strategies and assessment for impact, sustainability, and potential for broader replication.

Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

Retrieved on: 
Monday, February 5, 2024

“The accumulating talent bench at Lexeo has overseen some of the most transformative clinical development programs, drug approvals and product launches in rare disease and precision cardiovascular medicine,” said R. Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics.

Key Points: 
  • “The accumulating talent bench at Lexeo has overseen some of the most transformative clinical development programs, drug approvals and product launches in rare disease and precision cardiovascular medicine,” said R. Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics.
  • During her tenure, Dr. See Tai led the late-stage clinical development program of tafamidis for ATTR cardiomyopathy (ATTR-ACT), which achieved global regulatory approvals, and the Phase 3 LMNA dilated cardiomyopathy clinical program.
  • In addition to late-stage clinical development, Dr. See Tai was responsible for strategic clinical planning for early-stage development candidates such as those for other genetic cardiomyopathies and Duchenne Muscular Dystrophy.
  • Dr. Adler’s work has led to the development of a novel cardiovascular gene therapy candidate entering late-stage clinical development.

IVY'D Partners with Contra Costa County Independent Living Skills Program to Support Foster Youth College Preparation

Retrieved on: 
Monday, February 5, 2024

MARTINEZ, Calif., Feb. 5, 2024 /PRNewswire/ -- IVY'D, a renowned college admissions consulting service, just wrapped up a collaboration with the Contra Costa County Independent Living Skills Program to offer a series of free online workshops aimed at equipping foster youth with essential college preparation skills.

Key Points: 
  • MARTINEZ, Calif., Feb. 5, 2024 /PRNewswire/ -- IVY'D, a renowned college admissions consulting service, just wrapped up a collaboration with the Contra Costa County Independent Living Skills Program to offer a series of free online workshops aimed at equipping foster youth with essential college preparation skills.
  • Michelle Lee, the spokesperson for IVY'D, highlighted the initiative's significance, saying, "We understand the difficulties foster youth encounter in pursuing higher education.
  • By partnering with the Contra Costa County Independent Living Skills Program, we provided these young individuals with the necessary tools to succeed in college and beyond."
  • IVY'D specializes in mentoring students through the college admissions process, with services such as SAT/ACT preparation, resume building, and college essay writing.

Enact Completes Forward XOL Reinsurance Transaction as Part of its Diversified Credit Risk Transfer Program

Retrieved on: 
Thursday, February 1, 2024

This credit risk transfer (CRT) transaction covers a portion of expected new insurance written for the 2024 book year (policies written from January 1, 2024 through December 31, 2024), and is effective January 1, 2024.

Key Points: 
  • This credit risk transfer (CRT) transaction covers a portion of expected new insurance written for the 2024 book year (policies written from January 1, 2024 through December 31, 2024), and is effective January 1, 2024.
  • Reinsurance coverage is provided by a panel of reinsurers each currently rated “A-” or better by Standard & Poor’s or A.M. Best Company, Inc.
    “We’re pleased to have completed this XOL transaction,” said Rohit Gupta, President and CEO of Enact.
  • "Enact continues to be a market leader with its comprehensive CRT program and this transaction further reflects our ability to distribute and minimize credit risk and enhance our capital efficiency.
  • Enact is well-positioned to continue delivering value for our customers and stakeholders."

The Transportation Industry’s Biggest Names to Headline ACT Expo 2024

Retrieved on: 
Thursday, February 1, 2024

The 13th annual fleet-focused event is taking place May 20-23, 2024, at the Las Vegas Convention Center.

Key Points: 
  • The 13th annual fleet-focused event is taking place May 20-23, 2024, at the Las Vegas Convention Center.
  • “In addition, our 2024 ACT Expo keynote lineup promises to ignite inspiration and innovation, setting the stage for a transformative dialogue in the world of advanced transportation technologies and clean fuels.”
    Earlier this month, ACT Expo announced the full agenda and first keynote , Roger Alm, President of Volvo Trucks.
  • The massive expo hall will highlight more than 350 exhibitors and sponsors displaying new, advanced commercial vehicle technologies.
  • Supported by presenting sponsors Daimler Truck North America, Penske Transportation Solutions, and Shell, ACT Expo is the official annual meeting place for fleet transportation stakeholders focused on achieving both economic and environmental sustainability.

Aduro Clean Technologies Engages Crystal Research Associates to Provide Marketing and Investor Relations Services

Retrieved on: 
Tuesday, January 30, 2024

The Company announces that is has entered into a marketing and consulting agreement (the “CRA Agreement”) with an arm’s length investment research and analysis firm, Crystal Research Associates, LLC (“ Crystal Research Associates ”) of New York City, New York, to create and distribute an Executive Informational Overview and Quarterly Updates on the Company through Crystal Research Associates’ social media channels and online media distribution.

Key Points: 
  • The Company announces that is has entered into a marketing and consulting agreement (the “CRA Agreement”) with an arm’s length investment research and analysis firm, Crystal Research Associates, LLC (“ Crystal Research Associates ”) of New York City, New York, to create and distribute an Executive Informational Overview and Quarterly Updates on the Company through Crystal Research Associates’ social media channels and online media distribution.
  • For over twenty years, Crystal Research Associates has successfully articulated the exceptional stories of small- and mid- cap companies to the Wall Street investor community.
  • Through time-tested, well-established methods, Crystal Research Associates communicates objective, heavily researched, factual information for both institutional and retail audiences.
  • The engagement of Crystal Research Associates is aimed to increase the visibility of Aduro’s developing technologies in the United States and Internationally.

ACT EU Clinical Trials Analytics Workshop - January 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 January 2024, 13:00 (CET) to 26 January 2024, 13:00 (CET)

Retrieved on: 
Sunday, February 4, 2024

These data are used to support regulatory decision-making, but their potential uses extend far beyond that scope.

Key Points: 
  • These data are used to support regulatory decision-making, but their potential uses extend far beyond that scope.
  • During this event, stakeholders will have the opportunity to present/discuss how they are using or planning to use these data.
  • These discussions will help guide EU decision-makers on improving access and usability of clinical trials data.
  • After the event a prioritised list of use cases will be published as part of a clinical trials analytics research agenda, the delivery of which may be tied to public funding calls.